COMMUNIQUÉS West-GlobeNewswire

Provectus Biopharmaceuticals Announces Investor Webinar for 2026 Annual Meeting of Stockholders
08/06/2026
KNOXVILLE, Tenn., June 08, 2026 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that its 2026 annual stockholder meeting (the “Annual Meeting”), [...]
Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives
08/06/2026
Strengthening proprietary IP portfolio and next-generation product development pipeline KEY HIGHLIGHTS Cana Laboratories, Cosmos Health's wholly owned subsidiary, acquires international patent application WO2025108566A1 [...]
Telitacicept Receives NMPA Conditional Approval for the Treatment of IgA Nephropathy in China
08/06/2026
First and only approved BAFF/APRIL-targeting therapy for IgA nephropathy (IgAN) Approval based on positive interim Phase 3 TELIGAN results generated by collaborator RemeGen and recently published in The New England [...]
Healthcare Financial Management Association (HFMA) announces Matthew E. Cox as National Chair along with new officers, board members
08/06/2026
NATIONAL HARBOR, Md., June 08, 2026 (GLOBE NEWSWIRE) -- Matthew E. Cox officially assumed the role of National Chair of the Healthcare Financial Management Association (HFMA) during an induction ceremony at the [...]
National Action Urged to Address Chronic Pain Crisis Among Women and Women Veterans in Canada
08/06/2026
HAMILTON, Ontario, June 08, 2026 (GLOBE NEWSWIRE) -- A newly released national report is calling for urgent, coordinated action to address chronic pain among women and women Veterans, outlining a roadmap for a pan- [...]
Sharecare to honor extraordinary nurses through The DAISY Foundation’s global recognition program
08/06/2026
Nurses at Sharecare now eligible to be nominated for The DAISY Award for Extraordinary Nurses® by patients, their families, and colleagues, with honorees selected twice per year ATLANTA, June 08, 2026 (GLOBE NEWSWIRE [...]
Appel À Une Action Nationale Pour Lutter Contre La Crise De La Douleur Chronique Chez Les Femmes Et Les Vétéranes Au Canada
08/06/2026
HAMILTON, Ontario, 08 juin 2026 (GLOBE NEWSWIRE) -- Un rapport national récemment publié appelle à une action urgente et coordonnée pour lutter contre la douleur chronique chez les femmes et les vétéranes et présente [...]
Alkeus Pharmaceuticals Announces First Patient Dosed in Pivotal Global Phase 3 NORTHSTAR Study of Oral Gildeuretinol in Stargardt Disease
08/06/2026
NORTHSTAR will evaluate the efficacy and safety of investigational oral gildeuretinol, designed to reduce the formation of toxic vitamin A dimers, a proven mechanism of Stargardt disease. The study will assess [...]
Rhea's Factory Wins Global Change Award 2026 for AI-Designed Enzymes Enabling Textile-to-Textile Recycling
08/06/2026
RheaCycle™ transforms polyester waste into virgin-quality building blocks, making circularity commercially viable BERKELEY, Calif., June 08, 2026 (GLOBE NEWSWIRE) -- Rhea's Factory, a biotechnology company developing AI [...]
Flyte (VTAK) Makes Strategic Investment in Volato (SOAR)
08/06/2026
VTAK Becomes Volato's Largest Shareholder through Acquisition of a 7.5% Ownership Stake Investment Supports Potential Collaboration across Aviation Platforms and Accelerates Growth Opportunities across Both Companies [...]
Koi Peptides Expands Research Catalog In June 2026
08/06/2026
Wyoming, WY, June 08, 2026 (GLOBE NEWSWIRE) -- Research peptide reference standards in the Koi Peptides laboratory catalog have broadened with the addition of new reference compounds for in vitro analytical use. Each [...]
Sparrow Pharmaceuticals Announces Phase 2a Data Showing Cardiometabolic Benefits of Clofutriben in Adults with Type 2 Diabetes
08/06/2026
Clofutriben improved HbA1c and other cardiometabolic parameters in patients with Type 2 diabetes in a 6-week, placebo-controlled, randomized Phase 2 trial Subset of participants with elevated cortisol (EC) risk factors [...]
Sangamo Therapeutics Announces Exploration of Strategic Alternatives to Maximize Value for Stakeholders
08/06/2026
RICHMOND, Calif., June 08, 2026 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (OTCQB Venture Market: SGMO), a genomic medicine company, today announced that, after extensive consideration of the company’s pipeline and [...]
Medera Expands Scientific Advisory Board with Leading Heart Failure and Cardiopulmonary Physiology Experts to Advance HFpEF Gene Therapy Program
08/06/2026
Appointments further strengthen clinical leadership as Medera advances its First-In-Human HFpEF gene therapy program toward key upcoming milestones BOSTON, June 08, 2026 (GLOBE NEWSWIRE) -- Medera Inc. (“Medera”), a [...]
Enovis Launches Spinamic® Hybrid Scoliosis Brace, Combining Corrective Performance with Improved Wearability for Children and Teens
08/06/2026
The DonJoy Spinamic® Hybrid Scoliosis Brace is a first-of-its-kind device that integrates rigid corrective elements into a breathable, adjustable design to improve both clinical outcomes and patient compliance in [...]
Teva’s Data on AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Highlight Long-Term Advances in Tardive Dyskinesia Treatment and Care
08/06/2026
New analysis from the IMPACT-TD Registry demonstrates that treatment with AUSTEDO and AUSTEDO XR led to reductions in Abnormal Involuntary Movement Scale (AIMS) scores in all participants, which were associated with [...]
Hyperion DeFi Reiterates Guidance on Sunset of USDH and Felix Markets
08/06/2026
DALLAS, June 08, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”) today reiterates that the sunset of USDH and Felix Markets does not change its full-year 2026 guidance of $ [...]
Intravacc Highlights Integrated Analytical Capabilities to Accelerate Vaccine and Biologics Development
08/06/2026
Advanced analytical services support partners from product characterization and assay development to GMP readiness and clinical manufacturing Intravacc offers state-of-the-art analytical methods for identity, content, [...]
Ambros Therapeutics Announces First Patient Dosed in Pivotal CRPS-RISE Phase 3 Clinical Trial of Neridronate in Patients with Complex Regional Pain Syndrome Type 1
08/06/2026
CRPS-RISE designed to support FDA regulatory submission for potential approval of neridronate in patients with CRPS-1 FDA has previously granted neridronate with Breakthrough Therapy, Fast Track, and Orphan Drug [...]

Pages